Congratulations to Dr. Andrew Leask, Schulich Dentistry Professor and a member of the interdisciplinary Bone and Joint Institute, who was awarded a major Arthritis Society grant. This grant is among seven announced nationally, as part of the Arthritis Society’s commitment to fund $2.1-million annually to researchers conducting cutting-edge projects during the next three years.
The Leask research team will examine whether a specific protein inhibitor might be used to halt or treat scleroderma fibrosis. Scleroderma is an auto-immune disease that results in the build-up of tough, fibrous scar tissue in the skin and other organs. They are working to discover whether YAP1 (yes-associated protein) is responsible for generating the scar tissue, and whether YAP1 inhibitors could be used to treat scleroderma.
Full article - Western News
MEDIA CONTACT: Debora Van Brenk, Media Relations Officer, Western University, 519-661-2111 x85165, or on mobile at 519-318-0657 and firstname.lastname@example.org
Schulich Dentistry Research Seminar Series presents a lecture on January 17, 2018 by:
Jacques E. Nor, DDS, MS, PhD Poster/Abstract
Professor and Chair, Department of Cariology, Restorative Sciences, Endodontics, Professor of Biomedical Engineering, College of Engineering, Professor of Otolaryngology, Medical School
University of Michigan
‘Therapeutic targeting of head and neck cancer stem cells’
10:30am | DSB 0010| All Welcome